Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (3): 243-248.DOI: 10.3969/j.issn.1673-8640.2024.03.006
Previous Articles Next Articles
LI Anqi, ZHANG Shuya, HE Shanna, CHEN Qiaoqiao, LÜ Qi, LÜ Wanfei, LI Chunxian, WANG Weihua, ZHENG Lin()
Received:
2022-09-07
Revised:
2023-04-20
Online:
2024-03-30
Published:
2024-04-24
CLC Number:
LI Anqi, ZHANG Shuya, HE Shanna, CHEN Qiaoqiao, LÜ Qi, LÜ Wanfei, LI Chunxian, WANG Weihua, ZHENG Lin. Rapid bacterial identification and drug susceptibility test of blood culture-positive samples[J]. Laboratory Medicine, 2024, 39(3): 243-248.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.03.006
细菌种类 | 常规培养+MS | 5 h培养+ MS | 分离胶离心 富集+MS | |||||
---|---|---|---|---|---|---|---|---|
菌株数/株 | 检出率/% | 菌株数/株 | 准确率/% | 菌株数/株 | 准确率/% | |||
肠杆菌科 | 76 | 36.02 | 73 | 96.05 | 71 | 93.42 | ||
非发酵菌科 | 42 | 19.91 | 30 | 71.43 | 28 | 66.67 | ||
葡萄球菌属 | 45 | 21.33 | 34 | 75.56 | 28 | 62.22 | ||
链球菌属 | 3 | 1.42 | 1 | 33.33 | 2 | 66.67 | ||
肠球菌属 | 29 | 13.74 | 20 | 68.97 | 15 | 51.72 | ||
其他 | 16 | 7.58 | 10 | 62.50 | 6 | 37.50 | ||
合计 | 211 | 100.00 | 168 | 79.62 | 150 | 71.09 |
细菌种类 | 常规培养+MS | 5 h培养+ MS | 分离胶离心 富集+MS | |||||
---|---|---|---|---|---|---|---|---|
菌株数/株 | 检出率/% | 菌株数/株 | 准确率/% | 菌株数/株 | 准确率/% | |||
肠杆菌科 | 76 | 36.02 | 73 | 96.05 | 71 | 93.42 | ||
非发酵菌科 | 42 | 19.91 | 30 | 71.43 | 28 | 66.67 | ||
葡萄球菌属 | 45 | 21.33 | 34 | 75.56 | 28 | 62.22 | ||
链球菌属 | 3 | 1.42 | 1 | 33.33 | 2 | 66.67 | ||
肠球菌属 | 29 | 13.74 | 20 | 68.97 | 15 | 51.72 | ||
其他 | 16 | 7.58 | 10 | 62.50 | 6 | 37.50 | ||
合计 | 211 | 100.00 | 168 | 79.62 | 150 | 71.09 |
病原菌名称 | 常规培养+MS | 5 h培养+MS | 分离胶离心富集+MS | |||||
---|---|---|---|---|---|---|---|---|
菌株数/株 | 检出率/% | 菌株数/株 | 准确率/% | 菌株数/株 | 准确率/% | |||
大肠埃希菌 | 35 | 16.59 | 32 | 91.43 | 30 | 85.71 | ||
肺炎克雷伯菌 | 41 | 19.43 | 41 | 100.00 | 41 | 100.00 | ||
金黄色葡萄球菌 | 15 | 7.11 | 13 | 86.67 | 10 | 66.67 | ||
人型葡萄球菌 | 10 | 4.74 | 8 | 80.00 | 7 | 70.00 | ||
表皮葡萄球菌 | 11 | 5.21 | 8 | 72.73 | 6 | 54.55 | ||
溶血葡萄球菌 | 5 | 2.37 | 3 | 60.00 | 2 | 40.00 | ||
头状葡萄球菌 | 4 | 1.90 | 2 | 50.00 | 3 | 75.00 | ||
鲍曼不动杆菌 | 15 | 7.11 | 11 | 73.33 | 10 | 66.67 | ||
铜绿假单胞菌 | 11 | 5.21 | 10 | 90.91 | 9 | 81.82 | ||
多噬伯克霍尔德菌 | 7 | 3.32 | 4 | 57.14 | 4 | 57.14 | ||
洋葱伯克霍尔德菌 | 9 | 4.27 | 5 | 55.56 | 5 | 55.56 | ||
粪肠球菌 | 8 | 3.79 | 8 | 100.00 | 7 | 87.50 | ||
屎肠球菌 | 21 | 9.95 | 12 | 57.14 | 8 | 38.10 | ||
其他 | 19 | 9.00 | 11 | 57.89 | 8 | 42.11 | ||
合计 | 211 | 100.00 | 168 | 79.62 | 150 | 71.09 |
病原菌名称 | 常规培养+MS | 5 h培养+MS | 分离胶离心富集+MS | |||||
---|---|---|---|---|---|---|---|---|
菌株数/株 | 检出率/% | 菌株数/株 | 准确率/% | 菌株数/株 | 准确率/% | |||
大肠埃希菌 | 35 | 16.59 | 32 | 91.43 | 30 | 85.71 | ||
肺炎克雷伯菌 | 41 | 19.43 | 41 | 100.00 | 41 | 100.00 | ||
金黄色葡萄球菌 | 15 | 7.11 | 13 | 86.67 | 10 | 66.67 | ||
人型葡萄球菌 | 10 | 4.74 | 8 | 80.00 | 7 | 70.00 | ||
表皮葡萄球菌 | 11 | 5.21 | 8 | 72.73 | 6 | 54.55 | ||
溶血葡萄球菌 | 5 | 2.37 | 3 | 60.00 | 2 | 40.00 | ||
头状葡萄球菌 | 4 | 1.90 | 2 | 50.00 | 3 | 75.00 | ||
鲍曼不动杆菌 | 15 | 7.11 | 11 | 73.33 | 10 | 66.67 | ||
铜绿假单胞菌 | 11 | 5.21 | 10 | 90.91 | 9 | 81.82 | ||
多噬伯克霍尔德菌 | 7 | 3.32 | 4 | 57.14 | 4 | 57.14 | ||
洋葱伯克霍尔德菌 | 9 | 4.27 | 5 | 55.56 | 5 | 55.56 | ||
粪肠球菌 | 8 | 3.79 | 8 | 100.00 | 7 | 87.50 | ||
屎肠球菌 | 21 | 9.95 | 12 | 57.14 | 8 | 38.10 | ||
其他 | 19 | 9.00 | 11 | 57.89 | 8 | 42.11 | ||
合计 | 211 | 100.00 | 168 | 79.62 | 150 | 71.09 |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
头孢哌酮-舒巴坦 | 57 | 84.21(48) | 89.47(51) | 73.68(42) | 73.68(42) | |
阿米卡星 | 60 | 86.67(52) | 96.67(58) | 76.67(46) | 91.67(55) | |
阿莫西林-克拉维酸 | 54 | 74.07(40) | 83.33(45) | 72.22(39) | 79.63(43) | |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
头孢吡肟 | 60 | 88.33(53) | 95.00(57) | 81.67(49) | 81.67(49) | |
头孢西丁 | 54 | 79.63(43) | 79.63(43) | 74.07(40) | 79.63(43) | |
头孢他啶-克拉维酸 | 60 | 66.67(40) | 88.33(53) | 63.33(38) | 81.67(49) | |
头孢曲松 | 54 | 81.48(44) | 85.19(46) | 70.37(38) | 85.19(46) | |
亚胺培南 | 60 | 78.33(47) | 96.67(58) | 88.33(53) | 91.67(55) | |
哌拉西林-他唑巴坦 | 60 | 78.33(47) | 90.00(54) | 66.67(40) | 78.33(47) | |
复方磺胺甲噁唑 | 60 | 95.00(57) | 100.00(60) | 90.00(54) | 96.67(58) | |
左氧氟沙星 | 60 | 75.00(45) | 90.00(54) | 76.67(46) | 78.33(47) | |
替加环素 | 56 | 94.64(53) | 100.00(56) | 91.07(51) | 100.00(56) | |
头孢呋辛酯 | 55 | 94.55(52) | 96.36(53) | 89.09(49) | 98.18(54) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
头孢哌酮-舒巴坦 | 57 | 84.21(48) | 89.47(51) | 73.68(42) | 73.68(42) | |
阿米卡星 | 60 | 86.67(52) | 96.67(58) | 76.67(46) | 91.67(55) | |
阿莫西林-克拉维酸 | 54 | 74.07(40) | 83.33(45) | 72.22(39) | 79.63(43) | |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
头孢吡肟 | 60 | 88.33(53) | 95.00(57) | 81.67(49) | 81.67(49) | |
头孢西丁 | 54 | 79.63(43) | 79.63(43) | 74.07(40) | 79.63(43) | |
头孢他啶-克拉维酸 | 60 | 66.67(40) | 88.33(53) | 63.33(38) | 81.67(49) | |
头孢曲松 | 54 | 81.48(44) | 85.19(46) | 70.37(38) | 85.19(46) | |
亚胺培南 | 60 | 78.33(47) | 96.67(58) | 88.33(53) | 91.67(55) | |
哌拉西林-他唑巴坦 | 60 | 78.33(47) | 90.00(54) | 66.67(40) | 78.33(47) | |
复方磺胺甲噁唑 | 60 | 95.00(57) | 100.00(60) | 90.00(54) | 96.67(58) | |
左氧氟沙星 | 60 | 75.00(45) | 90.00(54) | 76.67(46) | 78.33(47) | |
替加环素 | 56 | 94.64(53) | 100.00(56) | 91.07(51) | 100.00(56) | |
头孢呋辛酯 | 55 | 94.55(52) | 96.36(53) | 89.09(49) | 98.18(54) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
头孢哌酮-舒巴坦 | 30 | 100.00(30) | 100.00(30) | 100.00(30) | 100.00(30) | |
阿米卡星 | 24 | 100.00(24) | 100.00(24) | 91.67(22) | 91.67(22) | |
头孢吡肟 | 24 | 100.00(24) | 100.00(24) | 83.33(20) | 87.50(21) | |
头孢他啶-克拉维酸 | 30 | 100.00(30) | 100.00(30) | 100.00(30) | 100.00(30) | |
亚胺培南 | 25 | 100.00(25) | 100.00(25) | 100.00(25) | 100.00(25) | |
美罗培南 | 27 | 88.89(24) | 92.59(25) | 85.19(23) | 85.19(23) | |
哌拉西林-他唑巴坦 | 24 | 91.67(22) | 91.67(22) | 95.83(23) | 95.83(23) | |
复方磺胺甲噁唑 | 30 | 100.00(30) | 100.00(30) | 100.00(30) | 100.00(30) | |
左氧氟沙星 | 27 | 92.59(25) | 92.59(25) | 96.30(26) | 100.00(27) | |
环丙沙星 | 24 | 100.00(24) | 100.00(24) | 100.00(24) | 100.00(24) | |
替加环素 | 14 | 100.00(14) | 100.00(14) | 92.86(13) | 100.00(24) | |
黏菌素 | 15 | 86.67(13) | 100.00(15) | 93.33(14) | 100.00(15) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
头孢哌酮-舒巴坦 | 30 | 100.00(30) | 100.00(30) | 100.00(30) | 100.00(30) | |
阿米卡星 | 24 | 100.00(24) | 100.00(24) | 91.67(22) | 91.67(22) | |
头孢吡肟 | 24 | 100.00(24) | 100.00(24) | 83.33(20) | 87.50(21) | |
头孢他啶-克拉维酸 | 30 | 100.00(30) | 100.00(30) | 100.00(30) | 100.00(30) | |
亚胺培南 | 25 | 100.00(25) | 100.00(25) | 100.00(25) | 100.00(25) | |
美罗培南 | 27 | 88.89(24) | 92.59(25) | 85.19(23) | 85.19(23) | |
哌拉西林-他唑巴坦 | 24 | 91.67(22) | 91.67(22) | 95.83(23) | 95.83(23) | |
复方磺胺甲噁唑 | 30 | 100.00(30) | 100.00(30) | 100.00(30) | 100.00(30) | |
左氧氟沙星 | 27 | 92.59(25) | 92.59(25) | 96.30(26) | 100.00(27) | |
环丙沙星 | 24 | 100.00(24) | 100.00(24) | 100.00(24) | 100.00(24) | |
替加环素 | 14 | 100.00(14) | 100.00(14) | 92.86(13) | 100.00(24) | |
黏菌素 | 15 | 86.67(13) | 100.00(15) | 93.33(14) | 100.00(15) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
克林霉素 | 41 | 78.05(32) | 80.49(33) | 92.68(38) | 73.17(30) | |
庆大霉素 | 40 | 87.50(35) | 95.00(38) | 75.00(30) | 87.50(35) | |
莫西沙星 | 41 | 85.37(35) | 87.80(36) | 63.41(26) | 73.17(30) | |
呋喃妥因 | 41 | 73.17(30) | 92.68(38) | 82.93(34) | 82.93(34) | |
苯唑西林 | 40 | 57.50(23) | 70.00(28) | 65.00(26) | 75.00(30) | |
青霉素 | 41 | 68.29(28) | 85.37(35) | 51.22(21) | 85.37(35) | |
奎奴普丁-达福普汀 | 41 | 80.49(33) | 97.56(40) | 78.05(32) | 87.80(36) | |
利福平 | 40 | 90.00(36) | 95.00(38) | 82.50(33) | 82.50(33) | |
复方磺胺甲噁唑 | 40 | 82.50(33) | 95.00(38) | 75.00(30) | 97.50(39) | |
万古霉素 | 41 | 48.78(20) | 90.24(37) | 43.90(18) | 70.73(29) | |
利奈唑胺 | 40 | 87.50(35) | 100.00(40) | 65.00(26) | 75.00(30) | |
四环素 | 41 | 82.93(34) | 87.80(36) | 70.73(29) | 85.37(35) | |
左氧氟沙星 | 41 | 70.73(29) | 90.24(37) | 63.41(26) | 85.37(35) | |
红霉素 | 40 | 92.50(37) | 95.00(38) | 65.00(26) | 90.00(36) | |
环丙沙星 | 40 | 87.50(35) | 92.50(37) | 62.50(25) | 82.50(33) | |
替加环素 | 39 | 82.05(32) | 100.00(39) | 74.36(29) | 97.44(38) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
克林霉素 | 41 | 78.05(32) | 80.49(33) | 92.68(38) | 73.17(30) | |
庆大霉素 | 40 | 87.50(35) | 95.00(38) | 75.00(30) | 87.50(35) | |
莫西沙星 | 41 | 85.37(35) | 87.80(36) | 63.41(26) | 73.17(30) | |
呋喃妥因 | 41 | 73.17(30) | 92.68(38) | 82.93(34) | 82.93(34) | |
苯唑西林 | 40 | 57.50(23) | 70.00(28) | 65.00(26) | 75.00(30) | |
青霉素 | 41 | 68.29(28) | 85.37(35) | 51.22(21) | 85.37(35) | |
奎奴普丁-达福普汀 | 41 | 80.49(33) | 97.56(40) | 78.05(32) | 87.80(36) | |
利福平 | 40 | 90.00(36) | 95.00(38) | 82.50(33) | 82.50(33) | |
复方磺胺甲噁唑 | 40 | 82.50(33) | 95.00(38) | 75.00(30) | 97.50(39) | |
万古霉素 | 41 | 48.78(20) | 90.24(37) | 43.90(18) | 70.73(29) | |
利奈唑胺 | 40 | 87.50(35) | 100.00(40) | 65.00(26) | 75.00(30) | |
四环素 | 41 | 82.93(34) | 87.80(36) | 70.73(29) | 85.37(35) | |
左氧氟沙星 | 41 | 70.73(29) | 90.24(37) | 63.41(26) | 85.37(35) | |
红霉素 | 40 | 92.50(37) | 95.00(38) | 65.00(26) | 90.00(36) | |
环丙沙星 | 40 | 87.50(35) | 92.50(37) | 62.50(25) | 82.50(33) | |
替加环素 | 39 | 82.05(32) | 100.00(39) | 74.36(29) | 97.44(38) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
克林霉素 | 41 | 78.05(32) | 80.49(33) | 92.68(38) | 73.17(30) | |
庆大霉素 | 40 | 87.50(35) | 95.00(38) | 75.00(30) | 87.50(35) | |
莫西沙星 | 41 | 85.37(35) | 87.80(36) | 63.41(26) | 73.17(30) | |
呋喃妥因 | 41 | 73.17(30) | 92.68(38) | 82.93(34) | 82.93(34) | |
苯唑西林 | 40 | 57.50(23) | 70.00(28) | 65.00(26) | 75.00(30) | |
青霉素 | 41 | 68.29(28) | 85.37(35) | 51.22(21) | 85.37(35) | |
奎奴普丁-达福普汀 | 41 | 80.49(33) | 97.56(40) | 78.05(32) | 87.80(36) | |
利福平 | 40 | 90.00(36) | 95.00(38) | 82.50(33) | 82.50(33) | |
复方磺胺甲噁唑 | 40 | 82.50(33) | 95.00(38) | 75.00(30) | 97.50(39) | |
万古霉素 | 41 | 48.78(20) | 90.24(37) | 43.90(18) | 70.73(29) | |
利奈唑胺 | 40 | 87.50(35) | 100.00(40) | 65.00(26) | 75.00(30) | |
四环素 | 41 | 82.93(34) | 87.80(36) | 70.73(29) | 85.37(35) | |
左氧氟沙星 | 41 | 70.73(29) | 90.24(37) | 63.41(26) | 85.37(35) | |
红霉素 | 40 | 92.50(37) | 95.00(38) | 65.00(26) | 90.00(36) | |
环丙沙星 | 40 | 87.50(35) | 92.50(37) | 62.50(25) | 82.50(33) |
抗菌药物 | 例数 | 5 h培养与标准方法一致率 | 分离胶离心富集与标准方法一致率 | |||
---|---|---|---|---|---|---|
MIC/[%(例)] | 敏感性/[%(例)] | MIC/[%(例)] | 敏感性/[%(例)] | |||
克林霉素 | 41 | 78.05(32) | 80.49(33) | 92.68(38) | 73.17(30) | |
庆大霉素 | 40 | 87.50(35) | 95.00(38) | 75.00(30) | 87.50(35) | |
莫西沙星 | 41 | 85.37(35) | 87.80(36) | 63.41(26) | 73.17(30) | |
呋喃妥因 | 41 | 73.17(30) | 92.68(38) | 82.93(34) | 82.93(34) | |
苯唑西林 | 40 | 57.50(23) | 70.00(28) | 65.00(26) | 75.00(30) | |
青霉素 | 41 | 68.29(28) | 85.37(35) | 51.22(21) | 85.37(35) | |
奎奴普丁-达福普汀 | 41 | 80.49(33) | 97.56(40) | 78.05(32) | 87.80(36) | |
利福平 | 40 | 90.00(36) | 95.00(38) | 82.50(33) | 82.50(33) | |
复方磺胺甲噁唑 | 40 | 82.50(33) | 95.00(38) | 75.00(30) | 97.50(39) | |
万古霉素 | 41 | 48.78(20) | 90.24(37) | 43.90(18) | 70.73(29) | |
利奈唑胺 | 40 | 87.50(35) | 100.00(40) | 65.00(26) | 75.00(30) | |
四环素 | 41 | 82.93(34) | 87.80(36) | 70.73(29) | 85.37(35) | |
左氧氟沙星 | 41 | 70.73(29) | 90.24(37) | 63.41(26) | 85.37(35) | |
红霉素 | 40 | 92.50(37) | 95.00(38) | 65.00(26) | 90.00(36) | |
环丙沙星 | 40 | 87.50(35) | 92.50(37) | 62.50(25) | 82.50(33) |
[1] |
JOHNSON J, ROBINSON M L, RAJPUT U C, et al. High burden of bloodstream infections associated with antimicrobial resistance and mortality in the neonatal intensive care unit in Pune,India[J]. Clin Infect Dis, 2021, 73(2):271-280.
DOI URL |
[2] |
SAFDAR N, MAKI D G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus,Enterococcus,gram-negative bacilli,Clostridium difficile,and Candida[J]. Ann Intern Med, 2002, 136(11):834-844.
DOI URL |
[3] |
TIMSIT J F, RUPPÉ E, BARBIER F, et al. Bloodstream infections in critically ill patients:an expert statement[J]. Intensive Care Med, 2020, 46(2):266-284.
DOI |
[4] |
IBRAHIM E H, SHERMAN G, WARD S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting[J]. Chest, 2000, 118(1):146-155.
DOI PMID |
[5] | NABAL DÍAZ S G, ALGARA ROBLES O, GARCÍA-LECHUZ MOYA J M. New definitions of susceptibility categories EUCAST 2019:clinic application[J]. Rev Esp Quimioter, 2022, 35(Suppl 3):84-88. |
[6] |
HUMPHRIES R, BOBENCHIK A M, HINDLER J A, et al. Overview of changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing,M100,31st edition[J]. J Clin Microbiol, 2021, 59(12):e0021321.
DOI URL |
[7] |
ÅKERLUND A, JONASSON E, MATUSCHEK E, et al. EUCAST rapid antimicrobial susceptibility testing(RAST)in blood cultures:validation in 55 European laboratories[J]. J Antimicrob Chemother, 2020, 75(11):3230-3238.
DOI URL |
[8] | CHANDRASEKARAN S, ABBOTT A, CAMPEAU S, et al. Direct-from-blood-culture disk diffusion to determine antimicrobial susceptibility of gram-negative bacteria:preliminary report from the clinical and laboratory standards institute methods development and standardization working group[J]. J Clin Microbiol, 2018, 56(3):e01678. |
[9] | 尚军, 李修远, 王丽赟, 等. 优化差速离心法在血培养报警瓶MALDI-TOF MS细菌鉴定中的应用[J]. 临床检验杂志, 2016, 34(12):913-918. |
[10] | DON S. A new method for rapid phenotypic antimicrobial susceptibility testing directly from patient samples[J]. Open Forum Infect Dis, 2018, 5(Suppl 1):S468-S469. |
[11] | 陈云波, 嵇金如, 应超群, 等. 2018至2019年度全国血流感染细菌耐药监测报告[J]. 中华临床感染病杂志, 2021, 14(1):32-45. |
[12] |
陈峰, 李媛睿, 皇甫昱婵, 等. 分离胶促凝管联合 MALDI-TOF MS直接检测血培养阳性细菌[J]. 检验医学, 2015, 30(2):113-121.
DOI |
[13] | QUESADA M D, GIMÉNEZ M, MOLINOS S, et al. Performance of VITEK-2 compact and overnight MicroScan panels for direct identification and susceptibility testing of gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles[J]. Clin Microbiol Infect, 2010, 16(2):137-140. |
[14] |
CHEN Y, PORTER V, MUBAREKA S, et al. Rapid identification of bacteria directly from positive blood cultures by use of a serum separator tube,smudge plate preparation,and matrix-assisted laser desorption ionization-time of flight mass spectrometry[J]. J Clin Microbiol, 2015, 53(10):3349-3352.
DOI URL |
[15] | 陆燕飞, 刘根焰, 张晓慧, 等. 质谱快速鉴定联合直接药敏试验在肠杆菌目细菌血流感染诊断中的应用评估[J]. 临床检验杂志, 2021, 39(11):822-827. |
[16] |
乔玉莉, 黄宗帅, 田月如, 等. 血培养瓶增菌法快速鉴定和快速药物敏感性试验可行性分析[J]. 检验医学, 2021, 36(3):270-274.
DOI |
[1] | HUANG Yuan, CHEN Feng, MAO Leili, ZHANG Linglin, LÜ Qian, YAN Jun, CUI Wei. Application of serum peptidomics based on MALDI-TOF MS in the differential diagnosis of benign and malignant pancreatic diseases [J]. Laboratory Medicine, 2023, 38(1): 1-7. |
[2] | CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694. |
[3] | CHU Minjun, LI Xiaojuan, HUANG Hailin, LI Jue, MA Mingbiao, DU Tingyi, WANG Haiping. Influence of delayed entry on fastidious bacterium culture in 2 blood culture systems [J]. Laboratory Medicine, 2022, 37(3): 209-212. |
[4] | LIU Congcong, LI Jiaping, ZHOU Hongwei. Performance evaluation of 2 mass spectrometry systems in clinical microbial identification [J]. Laboratory Medicine, 2022, 37(11): 1084-1088. |
[5] | YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973. |
[6] | LI Yanchun, TIAN Bin, YUE Na, HU Zhidong. Analysis for distribution and drug resistance of fungemia pathogen from 2014 to 2020 in a Tianjin hospital [J]. Laboratory Medicine, 2021, 36(8): 800-804. |
[7] | YU Jiajia, LI Yuanrui, LIU Ying. MALDI-TOF MS combined with SDS and SAP pretreatment for rapid identification of positive blood culture [J]. Laboratory Medicine, 2021, 36(8): 864-868. |
[8] | DING Yiwei, HAN Zhihai. Identification of MALDI-TOF MS in determining the bacteria from artificial joint replacement infection [J]. Laboratory Medicine, 2021, 36(6): 656-661. |
[9] | HOU Weiwei, JIANG Lian, LI Dong. Clinical application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in the direct detection of blood culture positive specimens [J]. Laboratory Medicine, 2021, 36(4): 424-429. |
[10] | QIAO Yuli, HUANG Zongshuai, TIAN Yueru, GUAN Ming, JIANG Xiaofei. Primary exploration of rapid identification and drug sensitivity test of cerebrospinal fluid culture by blood culture enrichment method [J]. Laboratory Medicine, 2021, 36(3): 270-274. |
[11] | GUO Kunshan, WANG Shanmei, MA Bing, XU Junhong, ZHANG Jiangfeng, JING Nan, YAN Wenjuan, MA Qiong, LI Yi. Application of MALDI-TOF MS in methicillin-resistant Staphylococcus aureus rapid identification [J]. Laboratory Medicine, 2021, 36(2): 209-212. |
[12] | ZHENG Xin, HUANG Qi, XING Shan, TAN Xiaoli, DAI Shuqin, LIU Wanli, LIU Xiaomin. Evaluation of 2 blood cultures' performance with different antibiotic adsorption materials in detecting pathogens on BacT/ALERT system [J]. Laboratory Medicine, 2021, 36(12): 1258-1263. |
[13] | WANG Junjie, MA Bing, LI Yi, YAN Wenjuan, WANG Shanmei, MA Qiong, ZHANG Jiangfeng, XU Junhong, YUAN Youhua. Identification of bacteria directly by MALDI-TOF MS [J]. Laboratory Medicine, 2020, 35(7): 716-720. |
[14] | SHI Dake, NI Yuxing, HAN Lizhong, XIAO Chenlu. Influence factor analysis on 1 852 cases of blood culture [J]. Laboratory Medicine, 2019, 34(4): 305-308. |
[15] | ZHANG Jinghao, FANG Yi, ZHANG Yanmei, ZHAO Hu. MALDI-TOF MS combined with short-term culturing for determining pathogenic bacteria rapidly in midstream urine [J]. Laboratory Medicine, 2017, 32(4): 326-330. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||